Market Cap 64.44M
Revenue (ttm) 81.67M
Net Income (ttm) -55.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -67.80%
Debt to Equity Ratio -12.99
Volume 715,200
Avg Vol 667,876
Day's Range N/A - N/A
Shares Out 49.95M
Stochastic %K 21%
Beta 1.36
Analysts Hold
Price Target $2.38

Company Profile

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 855 896 8401
Fax: 855 404 0061
Address:
100 Campus Drive, 6th Floor, Marlborough, United States
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 8 at 1:25 PM
$AKYA completes merger with Quanterix - shares converted at 0.1461 $QTRX + $0.38 cash. Trading halted, delisting from Nasdaq effective immediately. While the deal provides liquidity relief, investors now face integration risks and diluted exposure. Proceed with caution - this was a survival move, not a growth story. https://www.sec.gov/Archives/edgar/data/1711933/000110465925066306/tm2520065d1_8k.htm
0 · Reply
G101SPM
G101SPM Jul. 8 at 1:17 PM
Intrigant value $AKYA $0.5261 per share. *DAC (dollar average cost) $2.28 (6.12.24). Co announced that it has completed its previously announced acquisition of Akoya Biosciences, Inc., establishing a scaled leader in the early detection of disease for the neurology, oncology and immunology markets. Under the terms of the amended merger agreement announced on April 29th, Quanterix issued approximately 7.8 million shares of its common stock and paid approximately $20 million in cash, in the aggregate, to holders of Akoya shares and other Akoya equity awards. As previously announced, Masoud Toloue and Vandana Sriram will continue to serve as Chief Executive Officer and Chief Financial Officer of the combined company. * Click SEARCH (magnifying glass) icon on our landing page to review the postings.
0 · Reply
TwongStocks
TwongStocks Jul. 7 at 8:12 PM
$AKYA NASDAQ Equity Corporate Actions Alert #2025 - 355 Information Regarding the Merger of Akoya Biosciences, Inc. (AKYA) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-355 At a special meeting held on July 7, 2025, the shareholders of Akoya Biosciences, Inc. (AKYA) will vote on the proposed merger with Quanterix Corp ($QTRX). If approved, the proposed merger is tentatively scheduled to close prior to the market open on July 8, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on July 7, 2025. If the merger closes as anticipated, the stock will remain halted on the day of closing (July 8th) and will be suspended effective July 9, 2025. Merger consideration: AKYA shareholders will receive $0.38 in cash and 0.1461 shares of QTRX for each share of AKYA held.
0 · Reply
Will2ride1
Will2ride1 May. 31 at 11:09 PM
$AKYA I like it
0 · Reply
JOHNSTOCKTON973
JOHNSTOCKTON973 May. 23 at 12:03 PM
$AKYA LETS GOO😎💪🚀🚀🚀🚀🚀🚀
0 · Reply
oldwisetrader
oldwisetrader May. 22 at 6:29 PM
$AKYA I was stopped out , good luck
0 · Reply
oldwisetrader
oldwisetrader May. 22 at 3:58 PM
$AKYA hop on board the train, we are heading to Two land
0 · Reply
JOHNSTOCKTON973
JOHNSTOCKTON973 May. 22 at 2:17 PM
$AKYA 😎💪🚀🚀🚀🚀🚀🚀🚀🚀🚀
1 · Reply
oldwisetrader
oldwisetrader May. 22 at 1:59 PM
$AKYA the best time ever for a new revised higher cash offer is Friday after market close on 3 day weekend
0 · Reply
oldwisetrader
oldwisetrader May. 22 at 1:51 PM
$AKYA above 1.37 will squeeze
0 · Reply
Latest News on AKYA
Akoya Biosciences Reports First Quarter 2025 Financial Results

May 12, 2025, 4:05 PM EDT - 2 months ago

Akoya Biosciences Reports First Quarter 2025 Financial Results


Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 9:43 PM EST - 8 months ago

Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript


Akoya Biosciences Reports Third Quarter 2024 Financial Results

Nov 14, 2024, 4:00 PM EST - 8 months ago

Akoya Biosciences Reports Third Quarter 2024 Financial Results


Akoya Biosciences: 2024 Could Be The Year To Own Their Stock

Dec 7, 2023, 7:45 AM EST - 1 year ago

Akoya Biosciences: 2024 Could Be The Year To Own Their Stock


Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 8 at 1:25 PM
$AKYA completes merger with Quanterix - shares converted at 0.1461 $QTRX + $0.38 cash. Trading halted, delisting from Nasdaq effective immediately. While the deal provides liquidity relief, investors now face integration risks and diluted exposure. Proceed with caution - this was a survival move, not a growth story. https://www.sec.gov/Archives/edgar/data/1711933/000110465925066306/tm2520065d1_8k.htm
0 · Reply
G101SPM
G101SPM Jul. 8 at 1:17 PM
Intrigant value $AKYA $0.5261 per share. *DAC (dollar average cost) $2.28 (6.12.24). Co announced that it has completed its previously announced acquisition of Akoya Biosciences, Inc., establishing a scaled leader in the early detection of disease for the neurology, oncology and immunology markets. Under the terms of the amended merger agreement announced on April 29th, Quanterix issued approximately 7.8 million shares of its common stock and paid approximately $20 million in cash, in the aggregate, to holders of Akoya shares and other Akoya equity awards. As previously announced, Masoud Toloue and Vandana Sriram will continue to serve as Chief Executive Officer and Chief Financial Officer of the combined company. * Click SEARCH (magnifying glass) icon on our landing page to review the postings.
0 · Reply
TwongStocks
TwongStocks Jul. 7 at 8:12 PM
$AKYA NASDAQ Equity Corporate Actions Alert #2025 - 355 Information Regarding the Merger of Akoya Biosciences, Inc. (AKYA) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-355 At a special meeting held on July 7, 2025, the shareholders of Akoya Biosciences, Inc. (AKYA) will vote on the proposed merger with Quanterix Corp ($QTRX). If approved, the proposed merger is tentatively scheduled to close prior to the market open on July 8, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on July 7, 2025. If the merger closes as anticipated, the stock will remain halted on the day of closing (July 8th) and will be suspended effective July 9, 2025. Merger consideration: AKYA shareholders will receive $0.38 in cash and 0.1461 shares of QTRX for each share of AKYA held.
0 · Reply
Will2ride1
Will2ride1 May. 31 at 11:09 PM
$AKYA I like it
0 · Reply
JOHNSTOCKTON973
JOHNSTOCKTON973 May. 23 at 12:03 PM
$AKYA LETS GOO😎💪🚀🚀🚀🚀🚀🚀
0 · Reply
oldwisetrader
oldwisetrader May. 22 at 6:29 PM
$AKYA I was stopped out , good luck
0 · Reply
oldwisetrader
oldwisetrader May. 22 at 3:58 PM
$AKYA hop on board the train, we are heading to Two land
0 · Reply
JOHNSTOCKTON973
JOHNSTOCKTON973 May. 22 at 2:17 PM
$AKYA 😎💪🚀🚀🚀🚀🚀🚀🚀🚀🚀
1 · Reply
oldwisetrader
oldwisetrader May. 22 at 1:59 PM
$AKYA the best time ever for a new revised higher cash offer is Friday after market close on 3 day weekend
0 · Reply
oldwisetrader
oldwisetrader May. 22 at 1:51 PM
$AKYA above 1.37 will squeeze
0 · Reply
Rferrer6
Rferrer6 May. 22 at 1:44 PM
$AKYA umm what?
0 · Reply
oldwisetrader
oldwisetrader May. 22 at 1:44 PM
$AKYA can’t believe this isn’t down today, what wrong
0 · Reply
oldwisetrader
oldwisetrader May. 21 at 8:40 PM
$AKYA considering it says this stock is 70 percent owned by the insiders I would have to assume a sweet cash offer would be tempting since the insiders own 73 percent of the 50 million outstanding shares ……
0 · Reply
DSTOCK80
DSTOCK80 May. 21 at 8:37 PM
$AKYA watches 324😁
0 · Reply
bzspy
bzspy May. 21 at 6:14 PM
$DTSS Grab the dips. 100M contract. this one is a sleeper. Accumulation zone. 🔥🔥 $AKYA looking solid. Holding nicely. $SEGG nice run today $MLGO could be consolidating for another leg.
0 · Reply
topstockalerts
topstockalerts May. 21 at 4:23 PM
Midday Top Gainers PT2 $EDBL $NAKA $MRM $GOOS $AKYA
0 · Reply
MrTicker
MrTicker May. 21 at 3:53 PM
$AKYA 11:45 AM EDT, 05/21/2025 (MT Newswires) -- Akoya Biosciences(AKYA) said in a Wednesday filing that it received an unsolicited acquisition proposal from an undisclosed third party, which offered $1.40 in cash for each Akoya common share.
0 · Reply
Stockttwits619
Stockttwits619 May. 21 at 3:19 PM
$GNLN $LGMK if ur bored $AKYA $MTVA $MLGO $
0 · Reply
oldwisetrader
oldwisetrader May. 21 at 2:30 PM
$AKYA for those new, they already were doing a merger, got an unsolicited offer of cash at 1.40 share which they said in 8k wasn’t good enough ,, so what will the next offer be ??? Best case scenario is a bidding war , one of these next mornings over the next few weeks might be entertaining …
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy May. 21 at 2:05 PM
$AKYA Needs to break 1.33$ and close above. 1.46 / 1.62$
0 · Reply
DSTOCK80
DSTOCK80 May. 21 at 2:04 PM
$AKYA pushing
0 · Reply
oldwisetrader
oldwisetrader May. 21 at 2:01 PM
$AKYA break above 1.33 should squeeze
0 · Reply